HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
Snapshot Science: How Can Single-cell Sequencing Overcome Computational Limitations?
Researchers from Children's Hospital of Philadelphia and New Jersey Institute of Technology (NJIT) developed new software that integrates multiple data sources from a single cell. This method provides important clues about how one change can lead to several others, enabling researchers to pinpoint the causes of genetic-based diseases.
Why it matters
With single-cell sequencing technologies, researchers can study gene expression, as well as messenger RNA, proteins, and even organelles in great detail. This is particularly relevant in cancer research, since the information can be used to determine the disease's genetic evolution. However, combining different cell characteristics for clustering analysis — for example, how a genetic variant might directly impact messenger RNA, protein synthesis, or epigenetics — presents a computational challenge. The CHOP/NJIT team's single-cell multimodal deep clustering (scMDC) software uses machine learning to analyze data about a single cell's multiple characteristics.
Who conducted the study
Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics, was first author, and Tian Tian, PhD, a postdoctoral researcher in the Center, co-authored the study.
How they did it
To test the clustering performance of the new model, the researchers employed simulation and real-data experiments to compare it against competing methods. The results showed that scMDC outperformed existing single cell single-modal and multimodal clustering approaches. The new software also utilizes linear scalability, meaning that more data sources provided to the scMDC yield better results.
"With this tool, we can better understand a single cell as an entity and not just as a fragmented unit," Dr. Hakonarson said.
"This is a significant advancement and allows us to integrate and put all of this information into biological perspective, which is particularly important when considering information on different diseases," Dr. Hakonarson said.
Where the study was published
The study appeared in Nature Communications.
Where to learn more
Read more about the Center for Applied Genomics.